We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Guidance for the pharmaceutical industry on how to apply to vary a veterinary Marketing Authorisation (MA) or Homeopathic Remedy.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
The penalties if you are caught taking or dealing drugs - drug classification, fines and prison sentences
This guidance specifies the standards for the continuous monitoring and sampling of stack emissions.
Information about how to register your homeopathic medicinal product through the Simplified Homeopathic Registration Scheme or the UK Homeopathic National Rules Scheme
The CMA investigated alleged excessive and unfair pricing, anti-competitive agreements and abusive conduct with respect to hydrocortisone tablets under Chapters I and II CA98 and Articles 101 and 102 TFEU.
Work out the VAT liability of goods and services supplied by health and care institutions and providers of non residential care to children.
Information and guidance on a range of medical devices for users and patients.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Guidance relating to blood clotting, myocarditis and Guillain-Barré Syndrome (GBS) after COVID-19 vaccination.
Hand luggage restrictions at UK airports - carry-on luggage, checked-in baggage, restricted items and liquids, electronic devices carried from Turkey, Lebanon, Egypt and Saudi Arabia
How to use a crossover randomised controlled trial to evaluate your digital health product.
How to label spirit drinks that you plan to sell in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.